About
Bio
Written for executives in the manufacturing, advertising, marketing, research and development, device and diagnostic, media and service supplier sectors. Content includes feature articles and departments covering the trends and events that impact sales, distribution, operations, new developments and emerging technologies in the pharmaceutical industry.
Editorial Submission Guidelines:
PharmaView: Please send an outline or first draft that addresses a topic or trend from an objective, non-promotional, insider's point of view. Drafts/outlines are reviewed by the editorial staff. Upon acceptance, author is interviewed to complete the article. The PharmaView averages 1,500 to 2,000 words and is accompanied by photography of the submitting author.
PharmaOutlet: The PharmaOutlet is original content provided by a contributing author and is intended to be provocative. This department averages 500 words. A photograph of the contributor and company affiliation accompanies the article.
PharmaCase: This feature article explores the challenges of implementing a tactical/innovative solution to a business challenge. Submissions should be accompanied by a draft outlining the goal, the steps toward achieving the goal, and the challenges encountered during the process. Upon acceptance, the author is interviewed to complete the editorial content.
PharmaCounsel: This feature article investigates regulatory, legislative, and legal issues that impact the industry.
The outlet offers a digital Podcast.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United States of America
Frequency
upgrade
Circulation
upgrade
Sectors
Biotechnology, Pharmaceutical Manufacturers, Pharmaceuticals
Bio
Written for executives in the manufacturing, advertising, marketing, research and development, device and diagnostic, media and service supplier sectors. Content includes feature articles and departments covering the trends and events that impact sales, distribution, operations, new developments and emerging technologies in the pharmaceutical industry. Editorial Submission Guidelines: PharmaView: Please send an outline or first draft that addresses a topic or trend from an objective, non-promotional, insider's point of view. Drafts/outlines are reviewed by the editorial staff. Upon acceptance, author is interviewed to complete the article. The PharmaView averages 1,500 to 2,000 words and is accompanied by photography of the submitting author. PharmaOutlet: The PharmaOutlet is original content provided by a contributing author and is intended to be provocative. This department averages 500 words. A photograph of the contributor and company affiliation accompanies the article. PharmaCase: This feature article explores the challenges of implementing a tactical/innovative solution to a business challenge. Submissions should be accompanied by a draft outlining the goal, the steps toward achieving the goal, and the challenges encountered during the process. Upon acceptance, the author is interviewed to complete the editorial content. PharmaCounsel: This feature article investigates regulatory, legislative, and legal issues that impact the industry. The outlet offers a digital Podcast.
Website
Social media
Location
Frequency
Circulation
Sectors
Biotechnology, Pharmaceutical Manufacturers, Pharmaceuticals
Most recent articles by PharmaVoice
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to PharmaVoice
-
SScience
Founded in 1880, with seed money from Thomas Edison, Science continues to be at the center of the very best in research across the sciences, with articles that consistently rank among the most cited in the world. Science articles are peer-reviewed, and written to appeal to both scientist and layman. Regular issue features include a news and comment section, book reviews, and coverage of scientific meetings and seminars. The News section features late-breaking news and in-depth news analysis. Compass, an opinion section, publishes letters and commentary by scientists on current science issues. The TechSight section focuses on leading edge techniques and technologies. Topics include: bioinformatics, genome sequencing, and protein sequencing. This section is published in the third issue every month. The Research section features original investigative research and reporting. Other departments include NetWatch, This Week in Science, ScienceScope, Random Samples and New Products.
ViewMMedscapeMedscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty.
ViewSScientific AmericanEstablished in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.
ViewTThe BMJThe BMJ is a leading international peer‑reviewed general medical journal that publishes high‑quality research, clinical reviews, expert analysis, news, opinion, education, evidence‑based guidance and commentary on clinical practice, public health, healthcare policy and related scientific and social issues affecting medicine and health professionals worldwide. It combines rigorous academic research with accessible content aimed at informing and improving healthcare decisions and outcomes globally.
ViewMMIT Technology ReviewEstablished in 1899 and written for venture capitalists and hi-tech executives as an informational source on innovative and improved technologies and their applications. Focuses on promoting the understanding of emerging technologies and their impact. Strives to promote the understanding of emerging technology and its impact on the world. Aims to promote the understanding of emerging technologies and to analyze their commercial, social and political impacts. Assists technology and business leaders including CXOs, entrepreneurs, researchers, venture capitalists and financiers as they drive the global economy.
ViewUse CisionOne to find more relevant outletsExplore journalists that write for PharmaVoice
-
M
-
M
-
T
Contact us to find more relevant journalistsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.